InvestorsHub Logo
Followers 13
Posts 697
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Wednesday, 08/14/2013 9:24:00 AM

Wednesday, August 14, 2013 9:24:00 AM

Post# of 130503
One key point in Geralds blog this AM:

"We intend to rely heavily on not-for-profit funding for certain indications in order to minimize shareholder dilution while maximizing patient benefit as we move MANF forward. The economies of scale created by having a single therapeutic candidate treat multiple diseases cannot be overstated, as development milestones in one area support further development in the others".

Its extremely important to know he is tring to minimize dilution; but they will need a significant capital raise sooner than later (I wish he spent some more time expanding on this important topic as well).

Lets get about $.04 I am confident it will happen today). GLTA!!!